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Background: Patellofemoral pain (PFP) is a prevalent condition commencing at 
various points throughout life. We aimed to provide an evidence synthesis 
concerning predictive variables for PFP, to aid development of preventative 
interventions.  
 
Methods: We searched Medline, Web of Science and SCOPUS until February 2017 
for prospective studies investigating at least one potential risk factor for future PFP. 
Two independent reviewers appraised methodological quality using the Newcastle-
Ottawa Scale. We conducted meta-analysis where appropriate, with standardised 
mean differences (SMD) and risk ratios calculated for continuous and nominal scaled 
data.  
 
Results: This review included 18 studies involving 4818 participants, of whom 483 
developed PFP (heterogeneous incidence 10%). Three distinct subgroups (military 
recruits, adolescents, recreational runners) were identified. Strong to moderate 
evidence indicates that age, height, weight, body mass index (BMI), body fat and Q-
angle are not risk factors for future PFP. Moderate evidence indicates that 
quadriceps weakness is a risk factor for future PFP in the military, especially when 
normalised by BMI (SMD -0.69, CI -1.02, -0.35). Moderate evidence indicates that hip 
weakness is not a risk factor for future PFP (multiple pooled SMD’s, range -0.09 to -
0.20), but in adolescents, moderate evidence that higher hip abduction strength is a 
risk factor for future PFP (SMD 0.71, CI 0.39,1.04).      
 
Conclusions: This review identifies multiple variables that do not predict future PFP, 
but identifies that quadriceps weakness in military recruits and higher hip strength in 
adolescents are risk factors for PFP. Identifying modifiable risk factors is an urgent 
priority to improve prevention and treatment outcomes.  
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INTRODUCTION 
Patellofemoral pain (PFP) is characterised by diffuse retropatellar or peripatellar 
symptoms throughout activities that load the knee during flexion, such as running, 
stair descent or squatting.[1] PFP is a common pathology in both adolescents[2] and 
adults[3], with prevalence in the general population reported as 22.7%[4]. However, 
the factors associated with PFP development and the incidence of the condition 
across a variety of populations remains under-evaluated due to limited prospective 
data and the homogeneity of studied populations.[4,5] As PFP is reported to be 
common across the lifespan and may be the precursor to patellofemoral 
osteoarthritis,[6,7] an improved understanding of the factors associated with the 
development of PFP and its incidence in differing populations is essential to prevent 
symptoms.  
 
With the incidence of PFP reported to be high[4] and symptoms persisting despite 
evidence based interventions,[8] further investigation is warranted to understand 
variables that are associated with PFP development and subsequently deliver 
evidence based preventative strategies. In 1992, Van Mechelen et al. presented a 
theoretical model described as the ‘sequence of prevention’ for sports injury (see 
figure 1) to guide injury prevention development.[9] With the incidence of PFP 
defined across populations[4] (stage one), an understanding of the aetiology (stage 
two) is required to identify the variables associated with the pathology 
development. A variable associated with future pathology should be manipulated as 
a preventative strategy within a randomised controlled trial (RCT) (stage 3). The 
effectiveness of the implemented strategy should then be appraised by re-examining 
the incidence within a specific population (stage 4).  
 
In 2012, Lankhorst et al. completed a systematic review of risk factors for PFP,[10] 
which identified a clear association between low knee extension strength and 
subsequent risk of PFP irrespective of measurement method, but no associations 
with other investigated variables. This is likely due to the low number of included 
studies (n=7), high data heterogeneity and data pooling being possible for just 13 out 
of 137 identified variables, but was unexpected given the known crossectional 
association between PFP and multiple pathomechanical variables such as muscle 
function and lower limb biomechanics.[11] 
 
Additional risk factors for future PFP have been identified within other systematic 
reviews using data from single studies. Increased navicular drop in military 
recruits[12], greater peak hip adduction during running[13] and increased forces at 
foot level during both walking and running[14] all increase the risk of future PFP. 
Whilst these findings are statistically significant, the absence of data pooling and the 
small to moderate effect sizes limit the impact and clinical applicability. Given the 
number of subsequently published prospective studies, an updated systematic 
review on this topic is now appropriate. 
 
The aim of this systematic review was to provide researchers and clinicians with 
evidence synthesis concerning predictive variables for PFP to aid the development of 
preventative interventions. The review was designed to synthesise the available 
evidence at stage two (aetiology) of the Van Mechelen model (see figure 1), and 
enable addressing stage three (preventative strategies). A secondary aim was to 
determine the incidence of PFP within the included studies, both as a heterogeneous 
condition and within specific homogenous cohorts. Specific objectives were to (i) 
establish prospective links between all investigated variables and future PFP (ii) 
identify risk factors and PFP incidence specific to individual homogenous cohorts and 
(iii) inform future studies on PFP prevention.   
METHODS 
This systematic review was completed in accordance with the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA) statement[15] and was 




The search terms used by Lankhorst et al[10] were duplicated for the purpose of this 
review. The following terms were used for PFP: arthralgia AND knee joint OR 
anterior knee pain OR (patell* OR femoropatell* OR femoro-patell* OR retropatell*) 
AND (pain OR syndrome OR dysfunction). Key words used for risk factors were: risk 
factor OR association OR relative risk OR odds ratio. We searched MEDLINE, Web of 
Science and SCOPUS from inception until February 2017, limited to papers published 
in the English language involving human subjects. In addition, a citing reference 
search was undertaken using Google Scholar up to March 2018, as well as hand 
searching of the reference lists of identified papers.  
	
Inclusion criteria 
A single investigator (AR) exported all studies identified by the search strategy to 
Endnote X7 (Thomson Reuters, Philadelphia). Eligibility criteria were adapted from 
the original review of Lankhorst et al,[10]: (i) studies involving male or female 
subjects who developed subsequent PFP (synonyms including retropatella pain, 
chondromalacia or anterior knee pain); (ii) at least one variable investigated as a risk 
factor for PFP; and (iii) prospective study designs. Studies with less than 20 PFP 
subjects were excluded by the review of Lankhorst et al,[10] but were included in 
this review. Two independent authors (BN and NL) reviewed all abstracts to 
determine eligibility. Full texts were screened where eligibility could not be 
determined by the abstract alone and any discrepancies were resolved at a 
consensus meeting.  
 
Quality assessment  
Methodological quality and risk of bias of included studies was determined by 
combining the Newcastle-Ottawa scale[16] (NOS) and appraising the number of 
events per variable[17]. Eligible studies were independently rated by two authors 
blind to study authors and institutions (SL and NL), with discrepancies resolved at a 
consensus meeting. The NOS contains 8 categories relating to methodological quality 
and each study was given an eventual score out of a maximum of 8 points. A score of 
0-3 points equated to a low quality (LQ) study, a score of 4-6 points equated to a 
moderate quality (MQ) study, with a score of 7-8 points required for a study to be 
given a score of high quality (HQ). In addition, HQ or MQ studies were reduced to 
either MQ or LQ respectively if they were determined to have a high risk of bias as a 
result of having less than 10 PFP participants for each investigated variable within 
their total sample.[17] Inter-rater reliability of the NOS was calculated using the 
percentage agreement method.  
 
Data extraction 
Data related to study characteristics were initially extracted from all included studies 
by one author (AR) and subsequently reviewed by a second author (BN). This 
included participant numbers (separating those who developed PFP and those who 
did not), characteristics of these groups (such as population), study duration and 
publication details (author and year). A second author (BSN) extracted all data 
pertaining to potential risk variables to be included in the meta-analysis. Means and 
standard deviations (SD) were extracted for variables of interest, which included (but 
were not limited to: anthropometrics and demographics (such as sex, body mass 
index (BMI)), biomechanical variables (such as kinematics and kinetics) and muscle 
function (such as strength or onset timing).  
 
Statistical methods  
Statistical analyses were undertaken using Review Manager 5.0 (The Cochrane 
Collaboration, Copenhagen, Denmark). Analyses were completed initially by one 
author (BSN) and subsequently reviewed by a second author (SDL). Means and SD’s 
were extracted for continuous scaled variables and used to calculate a standardised 
mean difference (SMD) with 95% confidence intervals (CI’s). Calculated individual or 
pooled SMDs were categorised as small (0.59), medium (0.60–1.19) or large (1.20) 
[18]. For nominal scaled variables, raw counts of injured and uninjured participants 
(e.g. PFP incidence in males and females) were extracted and used to calculate risk 
ratios (RR) with 95% CI’s, with a small effect indicated by a RR ≥ 2.0 and a large effect 
by a RR ≥ 4.0.[18]  
 
Data were pooled and has been presented as both a heterogeneous PFP cohort and 
further pooled by specific homogeneous subgroup where possible. Where 
methodological approaches between studies were deemed to be adequately 
comparable a meta-analysis was performed and the level of statistical heterogeneity 
for pooled data were determined using I2 statistics (heterogeneity defined as I2 > 
50%, p < 0.05). Random effects were used due to the variation in study methods and 
populations, and the typically low number of studies, therefore reducing the 
possibility of a type 1 error.[19]  
 
Only outcomes incorporating data from a minimum of two studies are presented in 
the main body of the review, due to the risk of reporting inappropriate levels of 
evidence where data pooling were not possible.  
 
Evidence based recommendations  
Levels of evidence were assigned to each calculated variable (pooled or otherwise) 
as described by Van Tulder et al,[20] which incorporate both assigned 
methodological quality of included studies and statistical outcomes:  
 
Strong evidence: Pooled results derived from three or more studies, including a 
minimum of two high quality studies that are statistically homogenous.  
 
Moderate evidence: Pooled results derived from multiple studies, including at least 
one high quality study, that are statistically heterogeneous; or from multiple 
moderate or low quality studies which are statistically homogenous.  
 
Limited evidence: Results from one high quality study or multiple moderate or low 
quality studies that are statistically heterogeneous.  
 




The search resulted in 3044 titles and abstracts being identified for screening.  
Following the removal of duplicates and studies that did not meet the inclusion 
criteria of the review, 18 studies involving a total of 4818 participants were included 
(see figure 2),[21-38] 483 of whom went on to develop symptoms consistent with 
PFP. This is indicative of a heterogeneous PFP incidence of 10%. Extracted data 
relating to study characteristics are presented in table 1. 
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282 9% 24 
Key: H=high; MD=moderate; L=low; M=male; F=female, USA=United States of 
America 
 
Subgroups and PFP incidence  
Three distinct subgroups were identified during the data extraction process. There 
were a total of seven studies involving military recruits,[21,23-25,28,36,37] six 
studies involving adolescents[22,26,27,29,31,38] and five studies involving 
recreational runners.[30,32-35] Studies involving military recruits involved a total of 
2435 participants, 280 of whom went on to develop PFP, reflective of an incidence of 
11% (range 3%-43%). Studies involving adolescents involved a total of 1118 
participants, 128 of whom went on to develop PFP, reflective of an incidence of 11% 
(range 5%-15%). Studies involving recreational runners involved a total of 1265 
participants, 75 of whom went on to develop PFP, reflective of an incidence of 6% 
(range 4%-21%). 
 
Quality assessment  
After evaluation of study quality and risk of bias,[16,17] a total of 9 HQ studies 
[21,22,24,25,27,28,33,36,37] and a further 9 MQ studies were identified.[23,26,29-
32,34,35,38] Mean percentage agreement for the NOS was 95% (range 89%-100%), 
indicating high inter-rater reliability (see table 2). The questions with the lowest 
percentage agreement were question 5 (does the study control for any confounding 
variables) and question 7 (was follow up time clearly defined).    
Table 2: individual study NOS scores and percentage agreement 
Question  
The cohort was 
truly or somewhat 
representative of a 
typical PFP cohort  
Selection of the 
non-PFP cohort was 
from the same 
community as the 
PFP cohort  
Ascertainment of 
PFP was made via 




outcome of interest 
was not present at 
start of study  
Cohorts were 
comparable on the 
basis of the design 
OR confounders 





medical records  
Follow up time 
was clearly 
defined  
Follow up was 
adequate (all 
subjects 
accounted for or 
≤20% attrition)  
 R1  R2  R1  R2  R1 R2  R1  R2  R1  R2  R1 R2  R1  R2  R1 R2  
Boling (‘09) [21] Y Y Y Y Y Y Y Y Y Y Y Y N N Y Y 
Duvigneaud (‘08) [25] Y Y Y Y Y Y Y Y Y ? Y Y Y N Y Y 
Finnoff (‘11) [26] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Foss (‘12) [22] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Herbst (‘15) [27] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Hetsroni (‘06) [28] Y Y Y Y Y Y N N N Y Y Y Y Y Y Y 
Holden (‘15) [29] Y Y Y Y Y Y Y Y N N Y Y Y Y Y Y 
Luedke (‘16) [30] Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y 
Milgrom (‘91) [23] N Y N Y Y Y Y Y N Y Y Y Y Y Y Y 
Myer (‘10) [31] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Noehren (‘13) [32] Y Y Y Y Y Y Y Y Y Y Y Y Y Y N ? 
Ramskov (‘15) [33] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Thijs (‘07) [36] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Thijs (‘08) [34] Y Y Y Y Y Y Y Y Y Y Y Y Y Y N N 
Thijs (‘11) [35] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Van Tiggelen (‘04) [37] Y Y Y Y Y Y Y Y Y ? Y Y Y Y Y Y 
Van Tiggelen (‘09) [24] Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Witvrouw (‘00) [38] Y Y Y Y Y Y Y Y Y Y Y Y Y Y N N 
Percentage Agreement 94% 94% 100% 100% 89% 100% 89% 94% 
Key: R=rater; Y=yes; N=no; ?=unable to determine 
 
Anthropometrics and demographics 
Data pooling were possible for seven individual variables (sex, height, weight, BMI, 
body fat percentage, age and limb length).  
 
Sex 
There is moderate evidence from three HQ[21,33,36] and four MQ[26,30,34,38] 
studies that sex is not a risk factor for future PFP (I2=73%, RR 1.33, CI 0.76,2.34) (see 
figure 3). This outcome does not change when pooling data only for military subjects 
(moderate evidence, I2=91%, RR 0.82, CI 0.25,2.74), adolescents (moderate evidence, 
I2=0%, RR 1.23, CI 0.38,2.07) or recreational runners (moderate evidence, I2=76%, RR 
3.08, CI 0.59,15.99). Whilst subgroup data pooling were non-significant, six of the 
seven included studies that reported data on sex had a greater proportion of 
females in their PFP cohort,[21,26,30,33,36,38] the highest of which was observed in 
the recreational runner subgroup.  
 
Height 
There is strong evidence from five HQ[24,25,33,36,37] and seven 
MQ[23,26,29,31,34,35,38] studies that height is not a risk factor for future PFP 
(I2=0%, SMD -0.08, CI -0.21,0.05) (see figure 4). This outcome does not change when 
pooling data for only military recruits (strong evidence, I2=41%, SMD -0.15, CI -
0.42,0.12), adolescents (moderate evidence, I2=0%, SMD 0.06, CI -0.23,0.35) or 
recreational runners (moderate evidence, I2=0%, SMD -0.15, CI -0.43,0.13).  
 
Weight 
There is strong evidence from five HQ[24,25,33,36,37] and seven 
MQ[23,26,29,31,34,35,38] studies that weight is not a risk factor for future PFP 
(I2=0%, SMD 0.02, CI -0.11,0.16) (see figure 5). This outcome does not change when 
pooling data for only military recruits (strong evidence, I2=0%, SMD 0.05, CI -
0.12,0.23), adolescents (moderate evidence, I2=28%, SMD -0.10, CI -0.46,0.25) or 
recreational runners (moderate evidence, I2=0%, SMD 0.10, CI -0.18,0.37). 
 
BMI 
There is strong evidence from four HQ[22,25,33,37] and three MQ[26,34,35] studies 
that BMI is not a risk factor for future PFP (I2=33%, SMD 0.10, CI -0.12,0.32) (see 
figure 6). This outcome does not change when pooling data for only military recruits 
(moderate evidence, I2=65%, SMD 0.09, CI -0.48,0.65), adolescents (moderate 
evidence, I2=75%, SMD 0.23, CI -0.72,1.18) or recreational runners (moderate 
evidence, I2=0%, SMD 0.15, CI -0.13,0.43).  
 
Body fat percentage 
There is moderate evidence from one HQ study[22] and 1 MQ study[38] that body 
fat percentage is not a risk factor for future PFP in adolescents (I2=0%, SMD -0.13, CI 
-0.40,0.13) (see figure 7). This variable was not investigated in either military recruits 
or recreational runners.  
 
Age 
There is strong evidence from three HQ[24,33,36] and five MQ 
studies[29,31,32,34,35] that age is not a risk factor for future PFP (I2=13%, SMD 0.06, 
CI -0.13,0.25) (see figure 8). This outcome does not change when pooling data for 
only military recruits (moderate evidence, I2=0%, SMD -0.05, CI -0.36,0.27), 
adolescents (limited evidence, I2=80%, SMD 0.04, CI -0.98,1.07) or recreational 
runners (moderate evidence, I2=0%, SMD 0.16, CI -0.09,0.40).  
 
Limb length 
There is limited evidence from two MQ studies[23,26] that limb length is not a risk 
factor for future PFP (I2=0%, SMD -0.01, CI -0.28,0.25). This variable was not 
investigated in recreational runners and no data pooling were possible within any 
individual subgroups.  
 
Lower limb alignment  
Data pooling were only possible for static Q-angle. Limited evidence from one 
HQ[21] and one MQ study[35] indicates that Q-angle is not a risk factor for future 
PFP (I2=0%, SMD 0.06, CI -0.22,0.33) (see figure 9). No data pooling were possible for 
any identified subgroup.  
    
Strength measures 
 
Quadriceps strength  
When pooling all available data for quadriceps strength, regardless of cohort or 
measurement method, there is strong evidence that quadriceps weakness is a risk 
factor for future PFP (moderate evidence, I2=65%, small SMD -0.32, CI -0.42, -0.22).  
 
Data pooling were only possible for the military subgroup for all quadriceps strength 
measures. There is moderate evidence from two HQ studies[25,37] that quadriceps 
weakness is a risk factor for future PFP when measured with an isokinetic 
dynamometer concentrically at 60˚/second (I2=0%, moderate SMD -0.66, CI -0.99,-
0.32) (see figure 10a) or concentrically at 240˚/second (I2=17%, small SMD -0.49, CI -
0.85,-0.12) (see figure 10b).  
 
For normalised quadriceps strength measured with an isokinetic dynamometer, 
there is moderate evidence from two HQ studies[25,37] that quadriceps weakness is 
a risk factor for future PFP when normalised by body mass  at 60˚/second (I2=0%, 
moderate SMD -0.61, CI -0.94,-0.28) (see figure 10c) or at 240˚/second (I2=0%, small 
SMD -0.53, CI -0.87,-0.20) (see figure 10d). When normalised by BMI, moderate 
evidence remains quadriceps weakness is a risk factor for future PFP when measured 
at both 60˚/second (I2=0%, moderate SMD -0.69, CI -1.02,-0.35) (See figure 10e) and 
240˚/second (I2=0%, small SMD -0.51, CI -0.84,-0.18) (see figure 10f).  
 
For quadriceps strength measured isometrically with a hand-held dynamometer 
(HHD), there is moderate evidence from one HQ[21] and one MQ study[23] that 




There is moderate evidence from two HQ studies[25,37] that hamstring strength is 
not a risk factor for future PFP in the military when measured with an isokinetic 
dynamometer concentrically at 60˚/second (I2=0%, SMD -0.09, CI -0.42,0.24) or 
240˚/second (I2=0%, SMD -0.10, CI -0.43,0.22). This variable was not investigated in 
either adolescents or recreational runners.  
 
Hip strength  
There is moderate evidence from one HQ[21] and two MQ studies[26,35] that hip 
extension (I2=0%, SMD -0.18, CI -0.44,0.09) (see figure 11a), hip internal rotation 
(I2=20%, SMD -0.09, CI -0.42,0.23) (see figure 11b) and hip external rotation (I2=0%, 
SMD -0.17, CI -0.43,0.10) (see figure 11c) strength, measured isometrically with a 
HHD, are not risk factors for future PFP. There is also limited evidence from two MQ 
studies[26,35] that both hip adduction strength (I2=0%, SMD -0.20, CI -0.67,0.28) 
(see figure 11d) and hip flexion strength (I2=52%, SMD -0.08, CI -0.82,0.67) (see 
figure 11e) are not risk factors for future PFP when measured with a HHD. No data 
pooling were possible for any identified subgroup for these strength measures.  
 
There is moderate evidence from two HQ[21,27] and two MQ[26,35] that hip 
abduction strength is not a risk factor for future PFP (I2=86%, SMD 0.25, CI -
0.38,0.88) (see figure 12a) when measured isometrically with a HHD. When data 
were pooled for the adolescent cohort, there is moderate evidence from one HQ[27] 
and one MQ study[26] that increased hip abduction strength is a risk factor for 
future PFP (I2=0%, SMD 0.71, CI 0.39,1.04) (see figure 12b) when measured with 
isometrically a HHD. Data pooling were not possible for the military or recreational 




Dynamic knee valgus angle  
Moderate evidence from one HQ study[21] and one MQ study[29] indicates that 
knee valgus angle during a jump land task is not a risk factor for future PFP (I2=99%, 




One HQ study[36] and one MQ study[34] investigated foot kinetics during walking 
and running respectively. When these data were pooled, moderate evidence 
indicates no significant associations between time to peak force at any investigated 
region of the foot, which included the hallux, the metatarsal heads and the 
medial/lateral heel.       
  
DISCUSSION  
This systematic review aimed to provide a synthesis of the evidence concerning 
predictive variables for PFP development. Despite the inclusion of 11 additional 
prospective studies and 55 additional variables when compared to the previous 
review of Lankhorst et al,[10] high data heterogeneity and a limited ability to pool 
data remained. Just two predictive variables, lower isokinetic quadriceps strength in 
the military and higher isometric hip abduction strength in adolescents, were 
identified. Heterogeneous incidence of PFP was 10%, with incidence also identified 
within the specific homogenous cohorts of military recruits (11%), adolescents (11%) 
and recreational runners (6%).  
 
Isokinetic quadriceps weakness is predictive of future PFP in a military cohort[25,37] 
and this is in agreement with the previous review of Lankhorst et al.[10] 
Unfortunately, the strength of this evidence has not changed, as no new prospective 
studies using an isokinetic dynamometer to measure quadriceps strength have been 
published since 2011. New data from two studies investigating isometric quadriceps 
strength in military cohorts,[21,23] not included by Lankhorst et al, demonstrated no 
significant association with future PFP. Whilst this could be interpreted as conflicting 
evidence, it could be that isometric muscle testing may not be sensitive enough to 
identify military recruits at risk of PFP. This limits the clinical applicability of these 
results, as isometric testing with a HHD is a more accessible tool for clinicians to use 
when measuring muscle strength.  
 
Quadriceps weakness was not identified as a risk factor for future PFP in an 
adolescent group[27]. Whilst this further validates the importance of investigating 
risk factors within homogenous groups, it is also important to consider the 
implications of these findings in relation to risk modification interventions within 
differing populations.  A similar disparity between adult and adolescent populations 
has been observed cross-sectionally, with no differences in hip or knee strength 
between adolescents with PFP and a group of asymptomatic controls matched for 
both age and sex[39], but significant strength deficits in adults with PFP compared to 
control groups.[40,41] These findings offer indications as to why rehabilitation 
programmes have been shown to be of significant benefit in adults with PFP,[42,43] 
but are of only limited additional benefit to education alone in adolescents.[44] 
 
In contrast to the quadriceps data, hip muscle weakness, regardless of test direction, 
was not a risk factor for future PFP in military recruits or recreational runners. 
However, higher baseline isometric hip abduction strength predicts future PFP in 
adolescents[26,27]. Herbst et al[27] make the suggestion that greater hip abduction 
strength could be the result of increased eccentric hip abductor demands due to 
increased peak hip adduction during dynamic tasks. When pooling data from both 
military and adolescent cohorts, dynamic knee valgus angle was also not a risk factor 
for future PFP. However, Holden et al[29] reported higher knee valgus displacement 
in adolescent females who develop PFP (mean difference 7.79˚). Despite these 
reported kinematic deficits, hip strength and altered kinematics during dynamic 
tasks are consistently negatively correlated,[45] contradicting this hypothesis.  
 
A more plausible explanation for the association between increased isometric hip 
abduction strength and future PFP in young adolescents is a high level of physical 
activity, common within this age group.[46] The mean age of the Herbst et al[27] 
cohort is 12.7 years and may therefore have higher lower limb muscle strength as a 
consequence of high physical activity levels. It may be that lower limb muscle 
strength correlates with duration of symptoms in adolescents, with strength deficits 
presenting later in life when symptoms persist and if activity levels subsequently 
reduce.[39] As a result, it is sensible to question the role of increasing muscle 
strength in adolescent cohorts as a preventative measure. It is advised that future 
prospective studies both report and stratify for activity levels when investigating the 
association between strength variables and future PFP.  
 
In 2011 Coppack et al[47] reported a significant reduction in PFP risk after 
completion of a quadriceps and gluteal strengthening programme when compared 
to a non-specific control group. It is surprising that an exercise intervention designed 
to increase quadriceps strength has not been investigated further, given both level 
one[10] and two[47] evidence identifying quadriceps weakness as a preventative 
treatment target. Whilst increased baseline hip abduction strength increases the risk 
for future PFP in adolescents, this is potentially a surrogate indicator of activity level. 
Given the positive results of education and load management interventions in this 
population,[44] we suggest prioritising these interventions in future in order to 
reduce the incidence of PFP in adolescents.   
 
Multiple variables often described as risk factors for future PFP, perhaps due to 
strong associations in cross-sectional studies, were not found to be so in this meta-
analysis. Participant height, weight, BMI, body fat percentage, age and Q-angle did 
not predict future PFP in any cohort. The recent systematic review of Hart et al[48] 
reports a cross-sectional association between high BMI and both PFP and 
patellofemoral osteoarthritis (PFOA) in adults, again perhaps due to a reduction in 
activity levels after symptom development.[49] Higher BMI was not a risk factor for 
future PFP in either adults or adolescents, nor was a high BMI linked to intervention 
outcomes in participants with PFP.[48] Whilst these data question the biologically 
plausible suggestion that a high BMI contributes to PFP development, it remains 
plausible that high BMI may influence treatment outcomes and this suggestion 
requires further investigation.[48]   
 
Using data from the work of Boling et al,[21] the previous 2012 review of Lankhorst 
et al[10] reported that females are at a higher risk of developing PFP within the 
military (odds ratio: 2.23, 95% CI 1.16,4.10). Our results are in conflict with this, with 
pooled data from 7 studies[21,26,30,33,34,36,38] identifying no significant links 
between the female sex and PFP development. Pooling data for the identified 
individual subgroups is also non-significant, but a greater proportion of females 
developing subsequent PFP was reported in six of the seven studies. The largest 
proportion of females occurs amongst the recreational runner subgroup and this is 
in fact statistically significant when a fixed-effects model is used for the meta-
analysis, meaning observed results are most likely a result of selection bias in source 
studies. However, given the low number of studies (n=3) and high heterogeneity, a 
fixed-effects model is inappropriate and increases the chance of sustaining a type I 
error.[19] Given the absence of a causal association between the female sex and 
future PFP, the frequent bias towards the female sex in trial sampling and the need 
to control for sex as a confounder may not be necessary. 
 
The heterogeneous incidence of PFP was 10% in this review, demonstrating that PFP 
affects up to one in ten persons across multiple populations. The recent systematic 
review of PFP incidence and prevalence by Smith et al[4] identified a wide range of 
PFP incidence amongst military recruits (9.7-571.4 cases per 1000 person-years), 
which is similar to the incidence range identified by this review (3-43%). The variance 
is likely explained by the four studies[24,25,28,37] included in this review not 
included by Smith et al,[4] and the three studies included by Smith et al[4] not 
eligible for inclusion within this review.[47,50,51] The incidence range for PFP within 
adolescent cohorts are identical (5-15%), despite two studies from this review[22,29] 
not being included by Smith et al.[4]  
 
Limitations and future research directions 
This review is not without limitations, which must be considered when interpreting 
the results. There is currently no accepted method for determining study 
methodological quality or ascertaining risk of bias. Whilst the NOS is advocated by 
the Cochrane Group, it is possible that using a different quality appraisal tool may 
have yielded different levels of eventual evidence. It should also be considered that 
the NOS does not have a component pertaining to the reliability of exposure data 
collection, focussing more on the validity of outcome data. As per the PRISMA 
guidelines[15] three databases were searched, but is it also possible that increasing 
the number of databases searched may have yielded additional studies for inclusion. 
An attempt was made to mitigate this risk by completing a citing reference search in 
Google Scholar in addition to hand searching the reference lists of included studies. 
It must be stressed that incidence data has been calculated only from included 
studies, and the addition of other epidemiology studies that do not fit the inclusion 
criteria of this review would have affected the figures reported. It was also not 
possible to express incidence data relative to a timeframe given the high 
heterogeneity observed between included studies.      
 
Some included studies provided data that were not suitable for inclusion in a meta-
analysis (i.e. no mean/SD or raw counts) and efforts to obtain raw data directly from 
study authors were unsuccessful. Despite the addition of 11 new studies, ability to 
pool data were limited, which is partly attributable to the 116 individual variables 
investigated across the 18 included studies that could not be pooled. A total of 8 
studies[26,29-32,34,35,38] failed to adhere to the rule of 10,[17] that is ensuring a 
minimum of 10 PFP events for each variable of interest, resulting in a high risk of bias 
and reduced methodological quality.   
 
Given the lack of associations identified by this review (pooled data or otherwise), it 
is sensible to suggest that perhaps the current body of research is not placing 
appropriate focus on variables of interest. Altered hip and knee kinematics during 
running are known to have moderate to strong cross-sectional association with 
PFP,[13] yet there remains just one prospective investigation of these variables in 
female runners only.[32] There is also an emerging evidence base surrounding the 
association between psychological variables and PFP, with levels of anxiety, 
depression, catastrophising and fear of movement reported to be elevated in 
persons with PFP by a recent systematic review.[52]  
 
The prospective studies included within this review have sought to detect an 
association between single variables and risk of PFP. The inherent limitation of this 
approach is the inability to consider interactions between multiple variables. 
Consequently, research needs to move towards a complex systems approach to 
better understand injury aetiology.[53] Rather than endeavouring to identify a 
singular causal factor, studies should be designed to investigate the interactions 
between a ‘web of determinants’ that are likely to be non-linear in nature.[54] This 
approach has significant methodological challenges and requires the use of a 
statistical learning approach such as a Bayesian network.[55] Examples of variables 
that could fit into a web of determinants for PFP from the published literature 
include muscle strength (quadriceps and gluteal), hip/knee kinematics, activity 
levels/sporting workload and psychosocial measures (see figure 13).  
 
No variable included within this systematic review identified a link with future PFP in 
recreational runners. High peak hip adduction is known to be associated with future 
PFP in female runners,[32] and future studies should further explore the causal 
associations between lower limb kinematics and PFP. Whist not presented in a 
fashion that allowed for data pooling, increased eccentric hip abduction strength 
reduces the risk of future PFP in recreational runners[33]. The distinct limitation of 
this study design is that no guidance was given to the included runners regarding 
training frequency or intensity which is likely to be a significant confounder, as more 
aggressive run volume progressions increase the risk of injury development.[56]   
CONCLUSION 
Quadriceps weakness, measured using an isokinetic dynamometer and whether or 
not normalised to either bodyweight or BMI, is a risk factor for future PFP in military 
recruits and should be investigated as a preventative strategy in a future RCT. Whilst 
higher hip abduction strength is a risk factor for future PFP in adolescents, this may 
simply be a composite of activity level. Overall, our understanding of what 
contributes to the development of PFP is inadequate and requires further scientific 
exploration, though the relationship between given variables and PFP risk is likely to 
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Summary Box – What are the new findings? 
 
• Heterogeneous incidence of PFP is 10%  
• Higher baseline hip abduction strength predicts future PFP development in 
adolescents.  
• Multiple variables (including sex, BMI and Q-angle) were no risk factors for 





Figure 1: the Van Mechelen model of injury prediction 
 
Figure 2: PRISMA search flow chart  
 
Figure 3: sex  
Forrest plot detailing risk ratios for sex when comparing participants who developed PFP with 
controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military recruits; A – 
adolescents; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – confidence 
intervals PFP – patellofemoral pain 
 
Figure 4: height  
Forrest plot detailing standardised mean differences for height when comparing participants who 
developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military 
recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – 
confidence intervals PFP – patellofemoral pain 
 
Figure 5: weight  
Forrest plot detailing standardised mean differences for weight when comparing participants who 
developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military 
recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – 
confidence intervals PFP – patellofemoral pain 
 
Figure 6: BMI 
Forrest plot detailing standardised mean differences for BMI when comparing participants who 
developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military 
recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – 
confidence intervals PFP – patellofemoral pain; BMI – body mass index  
 
Figure 7:  body fat percentage  
Forrest plot detailing standardised mean differences for body fat percentage when comparing 
adolescents who developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low 
quality; A – adolescents; SD – standard deviation; IV – inverse variance; CI – confidence intervals PFP 
– patellofemoral pain; % - percentage  
 
Figure 8:  age 
Forrest plot detailing standardised mean differences for age when comparing participants who 
developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military 
recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – 
confidence intervals PFP – patellofemoral pain;  
 
Figure 9:  Q-angle 
Forrest plot detailing standardised mean differences for Q-angle when comparing participants who 
developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – military 
recruits; R – recreational runners; SD – standard deviation; IV – inverse variance; CI – confidence 
intervals PFP – patellofemoral pain;  
 
Figures 10a-f:  Quadriceps strength 
Forrest plot detailing standardised mean differences for Quadriceps strength when comparing 
military recruits who developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low 
quality; M – military recruits; SD – standard deviation; IV – inverse variance; CI – confidence intervals 
PFP – patellofemoral pain;  
Figures 11a-e: Hip strength 
Forrest plot detailing standardised mean differences for hip strength when comparing participants 
who developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low quality; M – 
military recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – inverse 
variance; CI – confidence intervals PFP – patellofemoral pain;  
 
Figures 12a-b: Hip abduction strength 
Forrest plot detailing standardised mean differences for hip abduction strength when comparing 
participants who developed PFP with controls. HQ – high quality; MQ – medium quality; LQ – low 
quality; M – military recruits; A – adolescents; R – recreational runners; SD – standard deviation; IV – 
inverse variance; CI – confidence intervals PFP – patellofemoral pain;  
 
Figure 13: potential causal inference diagram for PFP   
 
 
